Breast cancer expresses functional NMDA receptors

Area of Science:

• Oncology
• Neuroscience
• Molecular Biology

Background:

• N-methyl-D-aspartate receptors (NMDARs) are critical in the central nervous system.
• Their role in cancer, particularly breast cancer, is largely unexplored.

Purpose of the Study:

• To investigate the expression and function of NMDAR1 and NMDAR2 receptors in breast cancer cells and tumors.
• To determine the impact of NMDAR antagonists on breast cancer growth.

Main Methods:

• RT-PCR to detect NMDAR1 and NMDAR2 mRNA in breast cancer cell lines (Mcf-7, SKBR3).
• Western blotting to confirm protein expression.
• In vitro cell growth assays using NMDAR antagonists (MK-801, memantine).
• Immunohistochemistry on human breast tumor tissues.
• In vivo tumor xenograft studies in mice.

Main Results:

• NMDAR1 and NMDAR2 mRNA and proteins are expressed in Mcf-7 and SKBR3 breast cancer cell lines.
• NMDAR antagonists MK-801 and memantine significantly inhibited cell growth (P < 0.0001).
• Immunohistochemistry confirmed NMDAR1 expression in all examined high-grade breast tumors.
• MK-801 completely arrested tumor xenograft growth in mice.

Conclusions:

• Active NMDAR receptors are expressed in most breast cancers.
• NMDARs play a crucial role in breast cancer cell survival and tumor growth.
• Targeting NMDARs represents a potential therapeutic strategy for breast cancer.